News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,729 Results
Type
Article (65272)
Company Profile (283)
Press Release (753159)
Multimedia
Podcasts (221)
Webinars (32)
Section
Business (251476)
Career Advice (3030)
Deals (38091)
Drug Delivery (228)
Drug Development (87114)
Employer Resources (203)
FDA (17991)
Job Trends (16607)
News (373895)
Policy (36493)
Tag
2025 Best Places to Work (22)
2026 Best Places to Work (33)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3074)
Academic (2)
Accelerated approval (75)
ADA (54)
Adcomms (43)
Allergies (231)
Alliances (53676)
ALS (291)
Alzheimer's disease (2132)
Antibody-drug conjugate (ADC) (759)
Approvals (18610)
Artificial intelligence (1037)
ASCO (344)
Autoimmune disease (526)
Automation (80)
Bankruptcy (398)
Belgium (45)
Best Places to Work (12386)
BIO (81)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (305)
BioSpace Insights (219)
Biotechnology (165)
Bispecific (60)
Bladder cancer (250)
Brain cancer (100)
Breast cancer (970)
Cancer (7939)
Cardiovascular disease (674)
Career advice (2614)
Career pathing (64)
CAR-T (456)
CDC (82)
CDMO (230)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (1216)
Cervical cancer (69)
Clinical research (77187)
Collaboration (2828)
Commercialization (71)
Company closure (9)
Compensation (1936)
Complete response letters (121)
COVID-19 (3040)
CRISPR (149)
CRO (8)
C-suite (1714)
Cystic fibrosis (181)
Data (11102)
Decentralized trials (4)
Denatured (68)
Depression (227)
Dermatology (209)
Diabetes (835)
Diagnostics (7786)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (48)
Drug discovery (501)
Drug pricing (250)
Drug shortages (40)
Duchenne muscular dystrophy (379)
Earnings (96514)
Editorial (85)
Employer branding (27)
Employer resources (180)
ESMO (435)
Events (132242)
Executive appointments (1383)
Eye disease (27)
FDA (23067)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (29)
Frontotemporal dementia (42)
Funding (2339)
Gene editing (310)
Generative AI (94)
Gene therapy (952)
GLP-1 (1384)
Government (5363)
Grass and pollen (6)
Guidances (445)
Healthcare (21000)
Hematology (232)
HIV (127)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (407)
Immuno-oncology (160)
Indications (298)
Infectious disease (3491)
Inflammatory bowel disease (283)
Inflation Reduction Act (17)
Influenza (164)
Intellectual property (386)
Interviews (568)
IPO (17463)
IRA (60)
Job creations (4479)
Job search strategy (2134)
JPM (71)
Kidney cancer (32)
Kidney disease (178)
Labor market (142)
Layoffs (706)
Leadership (69)
Legal (8979)
Licensing (129)
Liver cancer (121)
Longevity (55)
Lung cancer (1100)
Lung diease (25)
Lymphoma (566)
Machine learning (76)
Management (71)
Manufacturing (1588)
Marketing (40)
MASH (258)
Medical affairs (5)
Medical device (15343)
Medtech (15679)
Mergers & acquisitions (22190)
Metabolic disorders (2123)
Middle East (2)
mRNA (337)
Multiple sclerosis (260)
Multispecific (7)
NASH (24)
Netherlands (42)
Neurodegenerative disease (618)
Neuropsychiatric disorders (152)
Neuroscience (4299)
Neurotech (3)
NextGen: Class of 2026 (7336)
Non-profit (5059)
Now hiring (98)
Obesity (998)
Opinion (394)
Ovarian cancer (298)
Pain (349)
Pancreatic cancer (453)
Parkinson's disease (484)
Partnered (44)
Patents (796)
Patient advocacy (7)
Patient recruitment (981)
Patient selection (116)
Peanut (80)
People (67729)
Peptides (45)
Pharmaceutical (65)
Pharmacy benefit managers (41)
Phase 1 (23973)
Phase 2 (33837)
Phase 3 (25374)
Pipeline (14611)
Policy (421)
Postmarket research (2918)
Preclinical (10441)
Press Release (73)
Prostate cancer (408)
Psychedelics (104)
Radioligand (2)
Radiopharmaceuticals (435)
Rare diseases (1576)
Real estate (6722)
Recruiting (82)
Regenerative medicine (37)
Regulatory (29745)
Reports (93)
Research institute (2771)
Resumes & cover letters (466)
Rett syndrome (60)
RNA editing (34)
RSV (106)
Saudi Arabia (1)
Schizophrenia (228)
Series A (405)
Series B (282)
Service/supplier (8)
Sickle cell disease (149)
Special edition (37)
Spinal muscular atrophy (197)
Sponsored (57)
Startups (4143)
State (2)
Stem cells (7)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (166)
Switzerland (24)
Tariffs (103)
Tax incentives (2)
The Weekly (150)
Vaccines (1416)
Venture capital (182)
Weight loss (665)
Wet AMD (7)
Women's health (185)
Women in leadership (2)
Worklife (28)
Date
Today (204)
Last 7 days (914)
Last 30 days (3969)
Last 365 days (32961)
2026 (29882)
2025 (31842)
2024 (36866)
2023 (41897)
2022 (53263)
2021 (58043)
2020 (56887)
2019 (50232)
2018 (38172)
2017 (35196)
2016 (35475)
2015 (41453)
2014 (35173)
2013 (30732)
2012 (32799)
2011 (33240)
2010 (31930)
Location
Africa (1034)
Alabama (117)
Alaska (7)
Arizona (478)
Arkansas (17)
Asia (46812)
Australia (7942)
California (17093)
Canada (4702)
China (2021)
Colorado (767)
Connecticut (758)
Delaware (533)
Europe (105124)
Florida (2610)
Georgia (565)
Hawaii (5)
Idaho (69)
Illinois (1454)
India (153)
Indiana (780)
Iowa (35)
Japan (777)
Kansas (158)
Kentucky (66)
Louisiana (68)
Maine (84)
Maryland (2008)
Massachusetts (12289)
Michigan (463)
Minnesota (949)
Mississippi (8)
Missouri (178)
Montana (36)
Nebraska (31)
Nevada (199)
New Hampshire (93)
New Jersey (4516)
New Mexico (36)
New York (4463)
North Carolina (2203)
North Dakota (14)
Northern California (8785)
Ohio (524)
Oklahoma (30)
Oregon (51)
Pennsylvania (3293)
Puerto Rico (38)
Rhode Island (64)
South America (1388)
South Carolina (105)
South Dakota (2)
Southern California (6870)
Tennessee (285)
Texas (2865)
United States (60521)
Utah (523)
Vermont (2)
Virginia (425)
Washington D.C. (89)
Washington State (1364)
West Virginia (4)
Wisconsin (198)
Wyoming (6)
818,729 Results for "emmaus life sciences formerly known as emmaus medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emmaus Life Sciences Advances Middle East Strategy with Real-World Evidence Initiatives and Expansion into Africa
November 12, 2026
·
5 min read
Press Releases
Emmaus Life Sciences Reports Quarterly Financial Results - August 14, 2026
August 16, 2026
·
7 min read
Press Releases
Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer
August 31, 2026
·
2 min read
Press Releases
Emmaus Life Sciences Reports Quarterly Financial Results
May 17, 2026
·
6 min read
Press Releases
Emmaus Life Sciences Reports Annual Financial Results
March 31, 2026
·
7 min read
Press Releases
Emmaus Life Sciences Announces Strategic Transaction
December 30, 2025
·
5 min read
Policy
Emmaus Life Sciences Reports Delayed Filing of Annual Report
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported that the filing of its Annual Report on Form 10-K for the year ended December 31, 2023 will be delayed.
April 15, 2024
·
3 min read
Business
Emmaus Life Sciences Reports Management Changes
Emmaus Life Sciences, Inc. today reported that on August 18, 2023 the Board of Directors, including Yutaka Niihara, M.D., Ph.D, determined that Dr. Niihara would no longer serve as Chief Executive Officer of Emmaus, or as Chairman of the Board, in order to allow Dr. Niihara to pursue business opportunities in Ube, Japan and in India previously initiated by Emmaus.
August 23, 2023
·
5 min read
Policy
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that it has received marketing authorization from the Puerto Rico Department of Health for Endari®.
February 2, 2024
·
4 min read
Press Releases
Adora Life Science Announces the Appointment of Dr. Clinton D. Morgan as Chief Medical Officer
September 17, 2026
·
4 min read
1 of 81,873
Next